Company Filing History:
1 out of 3 
1 out of 5,076 
1 out of 279 
Years Active: 2023
Title: The Innovative Contributions of Julien Bellis
Introduction
Julien Bellis is a notable inventor based in Montpellier, France. He has made significant contributions to the field of biotechnology, particularly in the diagnosis and treatment of diseases related to cationic L-amino acid transporters.
Latest Patents
Julien Bellis holds a patent titled "Use of receptor-binding domain derived from bovine leukemia virus for the diagnosis or treatment of cationic L-amino acid transporter-related diseases." This patent discloses methods for diagnosing CAT1-related diseases, which include detecting CAT1 in a cell using a BLV.RBD ligand or its variants. Additionally, the patent outlines a BLV.RBD ligand for use in the treatment of CAT1-related diseases and/or BLV infections.
Career Highlights
Throughout his career, Julien has worked with prominent organizations such as Metafora Biosystems and the Centre National de la Recherche Scientifique. His work has focused on advancing the understanding and treatment of complex diseases, showcasing his dedication to scientific innovation.
Collaborations
Julien has collaborated with esteemed colleagues, including Svilena Ivanova and Donatella Giovannini. These partnerships have contributed to the development of groundbreaking research and innovative solutions in the field.
Conclusion
Julien Bellis exemplifies the spirit of innovation in biotechnology through his patent and collaborative efforts. His work continues to impact the diagnosis and treatment of critical health issues, highlighting the importance of research and development in this field.